Your browser doesn't support javascript.
loading
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities.
Wu, Nan-Chun; Feng, Yin-Hsun; Kuo, Yu Hsuan; Chen, Wei-Yu; Wu, Hong-Chang; Huang, Chien-Tai; Wang, Wen-Ching; Kang, Nai-Wen; Shih, Jhih-Yuan; Chen, Zhih-Cherng; Chang, Wei-Ting.
Afiliação
  • Wu NC; Division of Cardiovascular Surgery, Department of Surgery, Chi Mei Medical Center.
  • Feng YH; Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy and Science.
  • Kuo YH; Division of Oncology, Department of Internal Medicine.
  • Chen WY; Division of Oncology, Department of Internal Medicine.
  • Wu HC; Division of Oncology, Department of Internal Medicine.
  • Huang CT; Division of Oncology, Department of Internal Medicine.
  • Wang WC; Division of Oncology, Department of Internal Medicine.
  • Kang NW; Division of General Surgery, Department of Surgery.
  • Shih JY; Division of Oncology, Department of Internal Medicine.
  • Chen ZC; Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center.
  • Chang WT; Department of Health and Nutrition, Chia Nan University of Pharmacy and Science.
Acta Cardiol Sin ; 38(1): 39-46, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35068882

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Acta Cardiol Sin Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Acta Cardiol Sin Ano de publicação: 2022 Tipo de documento: Article